Bortezomib in Treating Patients With Relapsed or Refractory Cutaneous T-Cell Lymphoma
Clinical trial NCT00182637 · COMPLETED
Trial details
- NCT number
- NCT00182637
- Sponsor
- Jonsson Comprehensive Cancer Center
- Status
- COMPLETED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2004-07-01
- Primary completion
- 2010-09-01
- Enrollment
- 5
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.